Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alpha-synuclein and iron: two keys unlocking Parkinson’s disease
Paul Lingor, Eleonora Carboni, Jan Christoph Koch
Journal of Neural Transmission (2017) Vol. 124, Iss. 8, pp. 973-981
Closed Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Molecular mechanisms of ferroptosis and their involvement in brain diseases
Inês Costa, Daniel José Barbosa, Sofia Benfeito, et al.
Pharmacology & Therapeutics (2023) Vol. 244, pp. 108373-108373
Open Access | Times Cited: 168
The lysosome as a master regulator of iron metabolism
Francesca Rizzollo, Sanket More, Peter Vangheluwe, et al.
Trends in Biochemical Sciences (2021) Vol. 46, Iss. 12, pp. 960-975
Open Access | Times Cited: 138
Parkinson's disease: Alterations in iron and redox biology as a key to unlock therapeutic strategies
Linlin Ma, Mahan Gholam Azad, Mahendiran Dharmasivam, et al.
Redox Biology (2021) Vol. 41, pp. 101896-101896
Open Access | Times Cited: 104
m6A Demethylase FTO-Mediated Upregulation of BAP1 Induces Neuronal Ferroptosis via the p53/SLC7A11 Axis in the MPP+/MPTP-Induced Parkinson’s Disease Model
Zhengyu Li, Xin Chen, Wenwen Xiang, et al.
ACS Chemical Neuroscience (2025)
Closed Access | Times Cited: 2
Parkinson’s disease and iron
Hideki Mochizuki, Chi‐Jing Choong, Kousuke Baba
Journal of Neural Transmission (2020) Vol. 127, Iss. 2, pp. 181-187
Closed Access | Times Cited: 96
An attempt to elucidate the role of iron and zinc ions in development of Alzheimer’s and Parkinson’s diseases
Karolina Wojtunik‐Kulesza, Anna Oniszczuk, Monika Waksmundzka‐Hajnos
Biomedicine & Pharmacotherapy (2019) Vol. 111, pp. 1277-1289
Open Access | Times Cited: 84
Ferritinophagy‐Mediated Ferroptosis Involved in Paraquat‐Induced Neurotoxicity of Dopaminergic Neurons: Implication for Neurotoxicity in PD
Yong Zuo, Jinhong Xie, Xincheng Li, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 70
Emerging Therapeutic Strategies for Parkinson’s Disease and Future Prospects: A 2021 Update
Noha Gouda, Ahmed Elkamhawy, Jungsook Cho
Biomedicines (2022) Vol. 10, Iss. 2, pp. 371-371
Open Access | Times Cited: 57
Ferroptosis: A double-edged sword
Shengmei Wang, Qiuyan Guo, Lili Zhou, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 15
Iron Deposition Leads to Hyperphosphorylation of Tau and Disruption of Insulin Signaling
Wenbin Wan, Lan Cao, Bill Kalionis, et al.
Frontiers in Neurology (2019) Vol. 10
Open Access | Times Cited: 66
The molecular mechanism of ferroptosis and its relationship with Parkinson's disease
Yan Su, Yue Jiao, Sheng Cai, et al.
Brain Research Bulletin (2024) Vol. 213, pp. 110991-110991
Open Access | Times Cited: 7
Metal dyshomeostasis in the substantia nigra of patients with Parkinson's disease or multiple sclerosis
Asunción Carmona, Eleonora Carboni, Lucas Caldi Gomes, et al.
Journal of Neurochemistry (2024) Vol. 168, Iss. 2, pp. 128-141
Open Access | Times Cited: 6
Iron and manganese-related CNS toxicity: mechanisms, diagnosis and treatment
Pan Chen, Melissa S. Totten, Ziyan Zhang, et al.
Expert Review of Neurotherapeutics (2019) Vol. 19, Iss. 3, pp. 243-260
Open Access | Times Cited: 52
l ‐3,4‐dihydroxyphenylalanine ( l ‐DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha‐synuclein mouse models of Parkinson's disease
Jessica L. Billings, Sarah L. Gordon, Tristan Rawling, et al.
Journal of Neurochemistry (2019) Vol. 150, Iss. 1, pp. 88-106
Open Access | Times Cited: 31
Interaction of α-synuclein and Parkin in iron toxicity on SH-SY5Y cells: implications in the pathogenesis of Parkinson's disease
Upasana Ganguly, Anindita Banerjee, Sankha Shubhra Chakrabarti, et al.
Biochemical Journal (2020) Vol. 477, Iss. 6, pp. 1109-1122
Open Access | Times Cited: 30
Copper Induced Radical Dimerization of α-Synuclein Requires Histidine
Dinendra L. Abeyawardhane, Ricardo D. Fernández, Denver R. Heitger, et al.
Journal of the American Chemical Society (2018) Vol. 140, Iss. 49, pp. 17086-17094
Closed Access | Times Cited: 29
Polyamines in Parkinson’s Disease: Their Role in Oxidative Stress Induction and Protein Aggregation
M. G. Makletsova, Sergei P. Syatkin, В.В. Полещук, et al.
Journal of Neurology Research (2019) Vol. 9, Iss. 1-2, pp. 1-7
Open Access | Times Cited: 26
High Dietary Iron Supplement Induces the Nigrostriatal Dopaminergic Neurons Lesion in Transgenic Mice Expressing Mutant A53T Human Alpha-Synuclein
Fengju Jia, Ning Song, Weiwei Wang, et al.
Frontiers in Aging Neuroscience (2018) Vol. 10
Open Access | Times Cited: 23
Differential regulation of estrogen in iron metabolism in astrocytes and neurons
Manman Xu, Xu Tan, Na Li, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 4, pp. 4232-4242
Closed Access | Times Cited: 22
Immune system and new avenues in Parkinson’s disease research and treatment
Ava Nasrolahi, Fatemeh Safari, Mehdi Farhoudi, et al.
Reviews in the Neurosciences (2019) Vol. 30, Iss. 7, pp. 709-727
Closed Access | Times Cited: 20
Iron Dysregulation and Inflammagens Related to Oral and Gut Health Are Central to the Development of Parkinson’s Disease
Marthinus Janse van Vuuren, Theo Nell, Jonathan Carr, et al.
Biomolecules (2020) Vol. 11, Iss. 1, pp. 30-30
Open Access | Times Cited: 20
Modern conception of the pathogenesis of neurodegenerative diseases and therapeutic strategy
Igor Litvinenko, И. В. Красаков, Г. Н. Бисага, et al.
S S Korsakov Journal of Neurology and Psychiatry (2017) Vol. 117, Iss. 6, pp. 3-3
Open Access | Times Cited: 20
A novel treatment strategy to prevent Parkinson’s disease: focus on iron regulatory protein 1 (IRP1)
Thomas M. Berry, Ahmed A. Moustafa
International Journal of Neuroscience (2021) Vol. 133, Iss. 1, pp. 67-76
Closed Access | Times Cited: 15
The Construction and Characterization of Mitochondrial Ferritin Overexpressing Mice
Xin Li, Peina Wang, Qiong Wu, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 7, pp. 1518-1518
Open Access | Times Cited: 15
Low plasma serotonin linked to higher nigral iron in Parkinson’s disease
Leslie C. Jellen, Mechelle M. Lewis, Guangwei Du, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top